Announcements Trials

Browse Landscape

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Papillomavirus Infections 7 Uterine Cervical Neoplasms 5 Neuroendocrine Tumors 4 Neoplasms 4 Autoimmune Diseases 3 Ovarian Neoplasms 2 Myasthenia Gravis 2 Mesothelioma, Malignant 2 Lung Neoplasms 2 Venous Thrombosis 1 Venous Thromboembolism 1 Uterine Cervical Dysplasia 1 Thyroid Diseases 1 Thrombosis 1 Squamous Intraepithelial Lesions 1 Retinal Telangiectasis 1 Renal Insufficiency 1 Recurrence 1 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mesothelioma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphohistiocytosis, Hemophagocytic 1 Leukemia, Hairy Cell 1 Hemorrhage 1 Hematologic Neoplasms 1 Glioma 1 Glioblastoma 1

Interventions

Peripheral Blood Stem Cell Transplantation 19 fludarabine phosphate 13 Mycophenolic Acid 12 Whole-Body Irradiation 11 Tacrolimus 11 Cyclosporine 9 Psychiatric Rehabilitation 8 Cyclophosphamide 8 Therapeutics 7 Rituximab 6 Methotrexate 6 Flow Cytometry 5 Busulfan 5 Vorinostat 4 Polymerase Chain Reaction 4 Methylprednisolone 4 Filgrastim 4 merphos 3 Radiotherapy 3 Ondansetron 3 Interferon-alpha 3 Etoposide 3 Early Intervention, Educational 3 Dexamethasone 3 Calcium Dobesilate 3 Bortezomib 3 Alemtuzumab 3 obinutuzumab 2 liposomal amphotericin B 2 immunotoxin HA22 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Leukemia, Hairy Cell × Data Collection × Clear all

NCT02883946 2016-08-30

RITUX-LEUKEMIA

CHU de Reims

Other hematologic neoplasm

Leukemia, Hairy Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡